Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.33 |
| ▸ | TSHR | P16473 | 5/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | CA3 | P07451 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fluoride SCHEMBL7526226 | 1.00 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRALOX12CA1 | |
| SCHEMBL219794 | 0.96 | ALDH1A1 (0.40) | ALDH1A1TDP1TSHRALOX12CA1 | |
| SCHEMBL27585641 | 0.96 | ALDH1A1 (0.40) | ALDH1A1TDP1TSHRALOX12CA1 | |
| Iodide SCHEMBL11576797 | 0.92 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRALOX12CA1 | |
| Hydrochloric Acid SCHEMBL3127808 | 0.92 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRALOX12CA1 | |
| Hydrochloric Acid SCHEMBL3127792 | 0.92 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRALOX12CA1 | |
| Iodide SCHEMBL11576790 | 0.92 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRALOX12CA1 | |
| SCHEMBL6755001 | 0.92 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRALOX12CA1 | |
| Water SCHEMBL3133145 | 0.92 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRALOX12CA1 | |
| Bromide SCHEMBL11573797 | 0.92 | ALDH1A1 (0.38) | ALDH1A1TDP1TSHRALOX12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112794786-A | Method for producing polyfluorobenzene derivative from tetrachloroethylene byproduct | 衢州乾达科技有限公司 | 2021-05-14 | — | — | CN | claimed |
| US-20210399237-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-12-23 | — | — | US | disclosed |
| EP-0805815-B1 | Use of bismuth compounds for the manufacture of medicaments for the treatment of gastric disorders caused by Helicobacter pylori | NYCOMED IMAGING AS (NO) | 2002-04-10 | — | — | EP | disclosed |
| US-6303101-B1 | TREATING A GASTROINTESTINAL DISORDER, ESPECIALLY AN ULCER CAUSED BY HELIOBACTER PYLORI. | NYCOMED IMAGING AS (NO) | 2001-10-16 | — | — | US | disclosed |
| US-6117412-A | ADMINISTERING BISMUTH COMPOUND CONTAINING ADDITIONAL HEAVY ATOM AS CONTRAST ENHANCER; X-RAYS, MAGNETIC RESONANCE, ULTRASOUND, AND SCINTIGRAPHIC IMAGING | NYCOMED IMAGING AS (NO) | 2000-09-12 | — | — | US | disclosed |
| EP-0805815-A1 | BISMUTH COMPOUNDS | NYCOMED IMAGING A/S (NO) | 1997-11-12 | — | — | EP | disclosed |
| WO-1996022994-A1 | BISMUTH COMPOUNDS | NYCOMED IMAGING A/S (NO) | 1996-08-01 | — | — | WO | disclosed |
| US-4479960-A | 2,3,5,6-TETRAHYDRO-6-PHENYLIMIDAZO(2,1-B) THIAZOLE IN A DILUENT | BAYER AG (DE) | 1984-10-30 | — | — | US | disclosed |
| US-4414222-A | TETRAMISOLE OR LEVAMISOLE WITH AN ALCOHOL OR ESTER | BAYER AG (US) | 1983-11-08 | — | — | US | disclosed |
| US-4336262-A | Pour-on veterinary anthelmintic | FISONS LTD. (GB) | 1982-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210399237-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, ODC1 | ALDH1A1 139/4885TDP1 3248/4885TSHR 3400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.